本页面由Tiger Trade Technology Pte. Ltd.提供服务

Allogene Therapeutics Inc.

2.22
+0.07003.26%
盘后2.220.00000.00%16:00 EDT
成交量:332.23万
成交额:725.47万
市值:5.41亿
市盈率:-2.57
高:2.27
开:2.10
低:2.09
收:2.15
52周最高:2.80
52周最低:0.8621
股本:2.44亿
流通股本:1.68亿
量比:0.68
换手率:1.98%
股息:- -
股息率:- -
每股收益(TTM):-0.8652
每股收益(LYR):-0.8652
净资产收益率:-53.42%
总资产收益率:-26.82%
市净率:1.85
市盈率(LYR):-2.57

数据加载中...

2026/03/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/12

重要事件披露

Form 8-K - Current report
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/11

重要事件披露

Form 8-K - Current report
2025/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/13

重要事件披露

Form 8-K - Current report